Grepafloxacin
生产企业：Otsuka pharmaceutical co ltd
Grepafloxacin is a fluoroquinolone antibiotic used to treat various gram positive and gram negative bacterial infections.
Grepafloxacin is a fluoroquinolone antibiotic used to treat various gram positive and gram negative bacterial infections.
Grepafloxacin exerts its antibacterial activity by inhibiting bacterial topoisomerase II (DNA gyrase) and topoisomerase IV, essential enzymes for duplication, transcription, and repair of bacterial DNA.
For treatment of adults with mild to moderate infections caused by susceptible strains of Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
未检索到以该名称命名的专利
专利文献通常使用化学名或研发代号指代药物，而非通用名；且专利申请在提交约 18 个月后才公开，较新的药物可能尚未出现在这里。
